Back to Search Start Over

Controlling the Control Arm in Metastatic Castration-Resistant Prostate Cancer Trials: Best Standard of Care or the Minimum Standard of Care?

Authors :
Van Wambeke S
Vera-Badillo FE
Gyawali B
Source :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 May 10; Vol. 40 (14), pp. 1518-1521. Date of Electronic Publication: 2022 Feb 21.
Publication Year :
2022

Abstract

Competing Interests: Simon Van WambekeConsulting or Advisory Role: JanssenTravel, Accommodations, Expenses: Roche, Janssen-Cilag, Ipsen Francisco Emilio Vera-BadilloConsulting or Advisory Role: Bayer, AstraZeneca, Janssen OncologyResearch Funding: AstraZeneca/MedImmune (Inst) Bishal GyawaliConsulting or Advisory Role: Vivio HealthNo other potential conflicts of interest were reported.

Details

Language :
English
ISSN :
1527-7755
Volume :
40
Issue :
14
Database :
MEDLINE
Journal :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publication Type :
Academic Journal
Accession number :
35188830
Full Text :
https://doi.org/10.1200/JCO.21.02304